Rare Intraoperative Left Coronary Artery Dissection in Acute Type A Aortic Dissection: VA‐ECMO‐Assisted Coronary Artery Bypass Grafting Authors: Yuta Nakamura, Keita Saku, Suzu Homma, Noriaki Moriyama, Takashi Ota Published: 2025 ABSTRACT ABSTRACTIntraoperative coronary artery dissection may become apparent during periods of increased myocardial oxygen demand rather than at onset. In the case of cardiogenic shock undergoing venoarterial extracorporeal membrane oxygenation, the patient's preserved right heart function and slight improvement in left heart contraction due to circulatory support may have collectively prevented excessive cardiac load. Introduction The incidence of coronary artery dissection (CAD) in cases of acute type A aortic dissection (aTAAD) ranges from 6.1% to 14.1% [1]. Coronary artery involvement in aTAAD can result from retrograde extension of the dissection flap into the coronaries and compression or blockage of these vessels by the dissection flap, potentially causing myocardial ischemia. However, 6 of 20 patients (30%) present with aortic dissection and acute coronary involvement, without evidence of myocardial ischemia [2]. Therefore, the incidence of acute myocardial infarction due to CAD in aTAAD is 1%–2%, with a reported mortality rate of 8.2% [1, 3]. While there are reports of CAD being a complication of aTAAD, it is exceedingly rare for such cases to manifest immediately following the cessation of cardiopulmonary bypass [4]. In cases of cardiogenic shock following reduced coronary blood flow, prompt reperfusion therapy is recommended, ideally under the support of catecholamines and mechanical circulatory support (MCS). However, there is no consensus regarding the optimal choice of MCS, as this decision should be made based on the specific pathology and patient background [5]. Herein, we report a case of a patient with cardiogenic shock due to left CAD during surgery for aTAAD, which was successfully treated using coronary artery bypass grafting under venoarterial extracorporeal membrane oxygenation (VA‐ECMO) management designed to consider left ventricular unloading. This case report discusses the timing of circulatory collapse in the context of intraoperative CAD and examines considerations for MCS support selection. Case History A previously healthy 64‐year‐old woman was urgently transported to the emergency department due to sudden‐onset chest and neck pain. Chest contrast computed tomography revealed aTAAD; however, her vital signs were stable upon arrival, and surgery was scheduled the following day. The patient had a history of hypertension and dyslipidemia. She had no history of smoking or allergies or a family history of cardiovascular disease. Methods Investigations Initial investigations showed a heart rate of 59 beats per minute with sinus rhythm on 12‐lead electrocardiography; no ischemic changes were observed. Transthoracic echocardiography revealed moderate aortic regurgitation without pericardial effusion, and both systolic and diastolic functions were well‐preserved, with no regional wall motion abnormalities. Chest contrast computed tomography identified an entry tear in the ascending aorta, with dissection extending from the sinus of Valsalva to the right internal iliac artery. No malperfusion of the cervical branches was observed at this time. Based on these findings, the patient was diagnosed with aTAAD, classified as Stanford type A, DeBakey type I, and TEM AE1M0. Management No evidence of cardiac tamponade or malperfusion was observed, and circulation remained stable. The ascending aortic diameter measured 47 mm (< 50 mm), and urgent surgery was performed the following day for total arch replacement and frozen elephant trunk (FET) implantation. Anesthesia was induced uneventfully using propofol, fentanyl, and rocuronium. Monitoring included the insertion of an arterial line, a central venous catheter, a pulmonary artery catheter, and transesophageal echocardiography (TEE). Additionally, cerebral oximetry and bispectral index monitoring were applied. Intraoperative TEE during anesthesia induction showed moderate aortic regurgitation and dissection extending into the sinus of Valsalva but with a normal left main trunk (LMT) and no asynergy (Figure 1). Anesthesia was maintained without complications, and a 21‐Fr arterial cannula was inserted into the left femoral artery, with 22‐Fr and 30‐Fr venous cannulas placed in the superior and inferior vena cava, respectively, to establish a cardiopulmonary bypass (CPB). Femoral artery perfusion was chosen for two reasons. First, no dissection was observed in the axillary artery; however, certain cervical branches were affected by dissection without malperfusion. Second, no atherosclerotic lesions were noted in the aorta, reducing the likelihood of embolic complications. Selective cerebral perfusion was used for all three cervical branches, and circulatory arrest was induced at a bladder temperature of 28°C. Circulatory arrest times typically do not exceed 30 min at our institution; therefore, we routinely perform total arch replacement and FET procedures at moderate hypothermia of approximately 28°C instead of deep hypothermia. The patient's aortic regurgitation was attributed to increased false lumen pressure from the dissection; consequently, only intimal fixation was performed, with no intervention on the sinus of Valsalva or aortic valve. During this period, the surgeon examined the aortic root and found no evidence of CAD of Neri type B or C. After completing the distal anastomosis under circulatory arrest, circulation was resumed, and proximal anastomosis of the left subclavian artery branch was performed, followed by release of the aortic cross‐clamp. Although a linear shadow was noted in the LMT, the myocardial contraction was consistent with ischemic reperfusion injury (Figure 2). As the reconstruction of the arch branches was completed and the perfusion flow reached 1 L/min, the anterior wall contraction gradually decreased, while right ventricular function was preserved. Nicorandil and dobutamine were initiated, and the patient's blood pressure stabilized, allowing weaning from CPB. Subsequently, the lateral wall contraction weakened, and new mitral regurgitation developed, resulting in hemodynamic instability. The patient's electrolytes were adjusted, and adrenaline and noradrenaline were administered; however, electrocardiography gradually showed poor R‐wave progression in leads II, V4, and V5, progressing to ventricular fibrillation. Defibrillation and administration of nifekalant, magnesium sulfate, and lidocaine were performed to resolve the ventricular fibrillation; however, the patient's hemodynamics remained unstable. Consequently, VA‐ECMO was promptly initiated due to hypotension and the need for rapid hemodynamic support. Additionally, maintaining stable circulatory dynamics during the harvest of the great saphenous vein graft is necessary; therefore, VA‐ECMO was started at a low‐flow rate, with minimal continuous adrenaline infusion at 0.01 μg/kg/min. VA‐ECMO was performed using a 16.5‐Fr arterial cannula in the left femoral artery and a 21‐Fr venous cannula in the left femoral vein. It was started at 2.0 L/min, and the flow was adjusted to maintain a mean arterial pressure above 60 mmHg and minimize left ventricular end‐diastolic volume (LVEDV) and aortic regurgitation observed on TEE, achieving hemodynamic stability at 1.8 L/min. Intraoperative left CAD was identified as the cause, necessitating beating‐heart coronary artery bypass grafting (CABG). The great saphenous vein was used as the graft, with the proximal anastomosis to the brachiocephalic artery and the distal anastomosis to the left anterior descending artery (LAD). The ascending aorta was not used as the graft conduit due to extensive replacement. TEE findings at anesthesia induction. White arrows indicate a false lumen lodged in the sinus of Valsalva, with no penetration into the LMT: Type A by Neri classification. LMT, left main trunk; TEE, transesophageal echocardiography. TEE findings after cardiopulmonary withdrawal. Black arrows indicate the presence of linear shadows encroaching into the LMT; Type B by Neri classification. LMT, left main trunk; TEE, transesophageal echocardiography. Outcomes and Follow‐Up CABG was successfully performed with stable hemodynamics, improving anterior wall motion and reducing aortic regurgitation to a mild degree. The graft mean flow was measured at 65 mL/min with a pulsatility index of 1.7, both indicating adequate graft function. The duration of VA‐ECMO was four days, terminating on postoperative date 3. The patient was admitted to the intensive care unit for seven days, with a total hospital stay of 22 days. During this time, the patient developed left ventricular contraction failure, surgical site infection, and renal failure. The ejection fraction was 50% immediately postoperatively, decreasing to 13% on postoperative Day 2 and subsequently recovering to 38% at discharge. Intravascular ultrasound and coronary angiography confirmed complete resolution of CAD at the 5‐month postoperative follow‐up, with improved blood flow in the LMT and evidence of chronic ischemic changes in the LAD (Figure 3). Moreover, the great saphenous vein graft was occluded. Left ventricular contraction failure persisted, and implantation of an implantable cardioverter‐defibrillator was planned to prevent sudden cardiac death. Coronary angiography and intravascular ultrasound images from the follow‐up period. Left Panel: Coronary angiography demonstrating the resolution of the LMT dissection. The black arrows indicate the intact vessel, with no evidence of residual dissection. LMT, left main trunk. Right Panel: Intravascular ultrasound image of the left anterior descending artery. The white arrows indicate chronic changes associated with a previously resolved dissection, showing structural alterations in the vessel wall. Discussion Here, we reported a patient with cardiogenic shock due to left CAD during surgery for aTAAD, which was successfully treated using coronary artery bypass grafting under VA‐ECMO management designed to consider left ventricular unloading. Two key points were highlighted regarding the management of cardiogenic shock due to intraoperative left CAD during aTAAD surgery. First, circulatory collapse due to CAD can manifest not only immediately after dissection but also when the myocardial workload increases. Second, MCS approaches for cardiogenic shock due to reduced coronary artery blood flow should be considered on a case‐by‐case basis. In particular, VA‐ECMO requires continuous assessment and careful flow management because the loading conditions on the left ventricle differ based on the right and left heart functions. CAD complicates aTAAD in 8% of right coronary artery cases and 11% of left coronary artery cases [3]. The incidence of acute myocardial infarction due to CAD in aTAAD is 1%–2%, with a mortality rate of 8.2% [1, 3]. The Neri classification is used for coronary artery orifice dissection [6]. In the present case, transthoracic echocardiography before CPB showed dissection extending into the sinus of Valsalva but not involving the LMT, which was confirmed intraoperatively with no Neri type B or C findings. After the return of spontaneous circulation and before weaning from CPB, dissection of the LMT from the sinus of Valsalva was observed. This may have been due to endothelial damage from central suture needle insertion or dissection progression to the LMT from surrounding tissue manipulation. Postoperative coronary angiography and intravascular ultrasound confirmed complete resolution of the dissection and hematoma, with improved LMT blood flow but with chronic infarction in the LAD region. This suggests that the existing dissection extended into the LAD, forming a hematoma, and the resulting compression led to gradually progressing ischemia in the left circumflex artery region owing to restricted blood flow. However, reports on intraoperative CAD remain limited. One such report by Lou et al. described extensive left CAD complicated by aortic root replacement in a 61‐year‐old woman with renal fibromuscular dysplasia, resulting in circulatory collapse before CPB weaning [4]. In this case, anterior wall contraction became akinetic around the time of CPB weaning at a flow rate of 1 L/min, and lateral wall contraction decreased over time. Tanoue et al. found that weaning from CPB increased LVEDV and afterload, increasing myocardial oxygen consumption and workload [7]. In this case, anterior wall contraction worsened as myocardial oxygen consumption increased owing to decreased coronary blood flow from LMT stenosis and decreased CPB flow. Additionally, the ischemic areas expanded over time, likely due to LAD progression and local coronary perfusion reduction from hematoma compression. Recommendations for post‐acute myocardial infarction cardiogenic shock remain unclear. An intra‐aortic balloon pump (IABP) is frequently used; however, its efficacy in improving prognosis and ischemic areas was disproven in the IABP‐SHOCK II trial [8]. A current statement from the American Heart Association suggests considering VA‐ECMO and IMPELLA based on patient condition and background [5]. Herein, we used low‐flow VA‐ECMO and reviewed this decision. CABG was considered for ischemic reperfusion therapy, and the great saphenous vein was selected for grafting. The brachiocephalic artery was chosen for the proximal anastomosis owing to the difficulty in securing a bloodless field when clamping the ascending aorta to obtain a graft. Performing CABG with circulatory support while maintaining cardiac beating was deemed optimal to minimize the likelihood of requiring further CPB. Considerations for MCS device selection include FET impact, quick introduction, graft harvest time, left ventricular volume load reduction, coronary perfusion pressure maintenance, and hemostasis. Contact with the FET precluded the use of IABP and IMPELLA CP. The IMPELLA 5.5 is hemodynamically suitable for left heart failure with normal right heart function. However, VA‐ECMO was prioritized owing to its rapid implementation and the necessity of maintaining stable hemodynamics during graft harvesting. Additionally, experimental studies have suggested that, depending on the characteristics of the dissection lumen, the use of IMPELLA in the context of coronary artery dissection may exacerbate coronary perfusion by increasing false lumen pressure, which further supported the decision to prioritize VA‐ECMO [9]. Nevertheless, VA‐ECMO is well‐known to increase blood pressure and afterload with higher flow rates, necessitating meticulous management of left ventricular preload to prevent overload. In this case, hemodynamics stabilized at 1.8 L/min, maintaining a lower LVEDV than post‐ventricular fibrillation without ECMO support (Figure 4). Typically, left ventricular preload with VA‐ECMO balances the left ventricular preload reduction and afterload increase; however, right heart function can also affect preload. For example, Sakamoto et al. reported that right ventricular function influences preload; decreased right heart function prevents right ventricular output adjustment with ECMO flow changes, increasing left atrial pressure [10]. In the present case, the patient's preserved right heart function and slight left heart contraction improvement from circulatory support may have prevented excessive cardiac load. As a limitation, if the reduced left ventricular preload cannot be tolerated, resulting in biventricular failure progression, further left ventricular preload reduction options include adding IMPELLA 5.5 or inserting a left atrial vent tube [11]. Previous reports of IMPELLA and ECPELLA have indicated improvements in 30‐day mortality rates but high bleeding complication rates [12]. Considering the patient's post‐CPB coagulation factor depletion, ongoing hemostasis efforts, and the use of a left atrial vent tube only during CABG, management solely with VA‐ECMO was deemed appropriate. Estimated pressure‐volume loops. Estimated pressure‐volume loops for post‐VF (blue line) and 1.8 L/min VA‐ECMO (red line), based on TEE findings, mean arterial pressure, and pulmonary artery diastolic pressure. VA‐ECMO was set to the maximum flow rate that stabilized hemodynamics without increasing LVEDV and was maintained at 1.8 L/min. In this case, the patient's preserved right heart function, slight improvement in left heart contraction due to circulatory support, and improved diastolic function resulting from right heart unloading may have collectively prevented excessive cardiac load. LVEDV, left ventricular end‐diastolic volume; LVESV, left ventricular end‐systolic volume; MAP, mean arterial pressure; PAP diastole, pulmonary artery diastolic pressure; VA‐ECMO, venoarterial extracorporeal membrane oxygenation; VF, ventricular fibrillation. Theoretically, VA‐ECMO may increase the coronary sinus end‐pressure‐diastolic blood pressure gradient through retrograde blood flow and right heart drainage. Arterial retrograde flow and inotropes increase afterload, whereas venous drainage creates negative pressure near the coronary sinus, increasing the gradient and enhancing coronary blood flow. However, the LMT dissection in this case likely reduced this effect. Conclusion This case demonstrates the successful management of cardiogenic shock due to intraoperative left CAD during aTAAD surgery using VA‐ECMO adjusted for left ventricular load and beating‐heart CABG. Author Contributions Yuta Nakamura: investigation, visualization, writing – original draft. Keita Saku: supervision, writing – review and editing. Suzu Homma: investigation. Noriaki Moriyama: investigation, resources, writing – review and editing. Takashi Ota: project administration. Funding The authors have nothing to report. Ethics Statement Ethics approval was not required for this case report as it describes routine clinical care without experimental interventions. Written informed consent was obtained from the patient for the publication of this case report. Consent Written informed consent was obtained from the patient using Wiley's recommended consent form for publication. Conflicts of Interest Yuta Nakamura, Suzu Homma, and Takashi Ota have no conflicts of interest to declare. Keita Saku received research funding from Abiomed Japan K.K., NTT Research Inc., Asahi Kasei ZOLL Medical Corporation, Neuroceuticals Inc., and Zeon Medical Inc.; and honoraria from Abiomed Japan K.K. and Mallinckrodt Pharmaceuticals Inc. Noriaki Moriyama received honoraria from Abbott, Edwards Lifesciences, and Medtronic, and research funding from the Japanese Circulation Society.